Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Karyotyping01:17

Karyotyping

Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Diagnosis and Risk Stratification of Acute Myeloid Leukemia, Myelodysplasia -Related].

Zhongguo shi yan xue ye xue za zhi·2024
Same author

[The Prognostic Value of Del(1p32) in Patients with Newly Diagnosed Multiple Myeloma].

Zhongguo shi yan xue ye xue za zhi·2024
Same author

[Zhuyu Pills promote polarization of macrophages toward M2 phenotype to prevent atherosclerosis via PPARγ/NF-κB signaling pathway].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2024
Same author

[Comprehensive Diagnosis of Mantle Cell Lymphoma].

Zhongguo shi yan xue ye xue za zhi·2023
Same author

[Correlation between Expression Patterns of CD117/CD200 in Plasma Cells and Molecular Genetic Prognostic Parameters in Multiple Myeloma].

Zhongguo shi yan xue ye xue za zhi·2023
Same author

Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial).

Proceedings of the National Academy of Sciences of the United States of America·2021

Related Experiment Video

Updated: Jul 11, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

[Study on molecular cytogenetic abnormalities in multiple myeloma].

Shu-Yan Liu1, Jian-Yong Li, Li-Juan Chen

  • 1Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|September 20, 2007
PubMed
Summary

Molecular cytogenetic abnormalities, including 13q14 deletion and IgH gene translocation, are frequent in multiple myeloma. Further research is needed to understand their prognostic significance.

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Related Experiment Videos

Last Updated: Jul 11, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Context:

  • Multiple myeloma (MM) is a hematologic malignancy characterized by uncontrolled proliferation of plasma cells.
  • Understanding the molecular cytogenetic landscape of MM is crucial for diagnosis, prognosis, and therapeutic strategies.

Purpose:

  • To investigate the prevalence of specific molecular cytogenetic abnormalities in newly diagnosed multiple myeloma patients.
  • To identify common chromosomal aberrations, including 13q14 deletion, p53 deletion, and IgH gene translocations, in bone marrow plasma cells.

Summary:

  • This study analyzed bone marrow plasma cells from 23 untreated multiple myeloma patients using interphase fluorescence in situ hybridization.
  • Results showed a high frequency of 13q14 deletion (43.5%) and 14q32 translocations (47.8%), with 30.4% of cases exhibiting both abnormalities. P53 deletion was not detected.
  • The findings highlight the common occurrence of 13q14 deletion and IgH gene translocations in multiple myeloma.

Impact:

  • The high frequency of these genetic alterations underscores their potential role in multiple myeloma pathogenesis.
  • Further investigation into the relationship between 13q14 deletion, IgH gene translocations, and patient prognosis is warranted.
  • These findings contribute to the molecular characterization of multiple myeloma, potentially informing future risk stratification and treatment approaches.